CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • April 27th, 2021 • Palisade Bio, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 27th, 2021 Company Industry JurisdictionThis Contingent Value Rights Agreement, dated as of April 27, 2021 (this “Agreement”), by and among Seneca Biopharma, Inc., a Delaware corporation (“Parent”), American Stock Transfer & Trust Company, LLC, as CVR Agent (the “CVR Agent”), and Raul Silvestre, in his capacity (as an individual and not in a legal capacity intended to create an attorney client relationship), as the initial CVR Holders’ Representative (the “CVR Holders’ Representative”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • February 9th, 2021 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 9th, 2021 Company Industry JurisdictionThis Contingent Value Rights Agreement, dated as of _________, 20___ (this “Agreement”), by and among Seneca Biopharma, Inc., a Delaware corporation (“Parent”), [●], as CVR Agent (the “CVR Agent”), and [●], in [its/his/her] capacity as the initial CVR Holders’ Representative (the “CVR Holders’ Representative”).
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • December 21st, 2020 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledDecember 21st, 2020 Company Industry JurisdictionThis Contingent Value Rights Agreement, dated as of _________, 20___ (this “Agreement”), by and among Seneca Biopharma, Inc., a Delaware corporation (“Parent”), [●], as CVR Agent (the “CVR Agent”), and [●], in [its/his/her] capacity as the initial CVR Holders’ Representative (the “CVR Holders’ Representative”).